📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RCUS.
💹 Market Data
Market Cap$3.19B
Shares Outstanding125.77M
Float89.09M
Cash$822.00M
Debt$113.00M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 21.7% shares (2025Q4 vs prior)
209 institutional holders · 128.53M shares
#1
GILEAD SCIENCES, INC.
31.42M shares
#2
BlackRock, Inc.
15.00M shares
#3
VANGUARD GROUP INC
7.96M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest10.89M
Days to Cover11.2
% of Float12.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2018
4
INSIDER TRANSACTION
Jan 26, 2026
4
INSIDER TRANSACTION
Jan 26, 2026
4
INSIDER TRANSACTION
Jan 26, 2026
4
INSIDER TRANSACTION
Jan 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for RCUS
📊 RCUS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RCUS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.